Literature DB >> 19778827

[Diagnosis of total anomalous pulmonary venous connection using multi-slice spiral CT].

Zhi-hui Hu1, Si-yun Wang, You-you Yang.   

Abstract

OBJECTIVE: To assess the value of multi-slice spiral computed tomography (MSCT) in the diagnosis of total anomalous pulmonary venous connection (TAPVC).
METHODS: A retrospective analysis was conducted in 12 patients with the diagnosis of TAPVC established by MSCT. Multi-planar reconstruction (MPR), curved-planar reconstruction (CPR), volume rendering (VR), maximum intensity projection (MIP) and minimum intensity projection were performed in all the cases, and the results were analyzed in comparison with those of ultrasound echocardiography (12 cases) and surgical findings (10 cases). Cardiovascular angiography was performed in 2 cases.
RESULTS: In the 10 patients receiving surgical interventions, 7 presented with supracardiac TAPVC, 2 with cardiac TAPVC, and 1 with infracardiac TAPVC. MSCT allowed qualitative diagnosis and identified the location of the lesions in all the 10 surgical patients, whereas echocardiography established the diagnosis in only 5 patients. In the 2 cases undergoing cardiovascular angiography, the diagnosis was established in only 1 case without clear display of the draining vein.
CONCLUSION: MSCT combined with 3-dimensional reconstruction provides a noninvasive and accurate means for the diagnosis of TAPVC.

Entities:  

Mesh:

Year:  2009        PMID: 19778827

Source DB:  PubMed          Journal:  Nan Fang Yi Ke Da Xue Xue Bao        ISSN: 1673-4254


  2 in total

1.  Computed tomography features of supracardiac total anomalous pulmonary venous connection in an infant.

Authors:  Tariq Alam; Hidayatullah Hamidi; Mer Mahmood Shah Hoshang
Journal:  Radiol Case Rep       Date:  2016-05-14

2.  Computed tomography findings and preoperative risk factors for mortality of total anomalous pulmonary venous connection.

Authors:  Yonghua Xiang; Guanxun Cheng; Ke Jin; Xuehua Zhang; Yuan Yang
Journal:  Int J Cardiovasc Imaging       Date:  2018-06-25       Impact factor: 2.357

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.